Including (a) human lymphocyte B/BP35 class II anti-CD20/limited reference Anti-CD20/Anti-Anti-Reference limited reaction antibody (b) at least 0.001 to 1 p/V of at least one Surfactor is optional; (c) a sanitary cotton 1 to 100 mm; and for the treatment of related diseases. Together with CD20

摘要

Formulation containing Type II anti-cd20 Antibody, a Surfactant and buffer; use of the formulation because it is useful for treating Diseases associated with cancer.